BioNTech Completes Acquisition of InstaDeep to strengthen its pioneering position in the field of AI-powered drug discovery, design and development
MAINZ, Germany – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today the completion of the acquisition of InstaDeep Ltd. (“InstaDeep”), a leading global technology company in the field of artificial intelligence (“AI”) and machine learning (“ML”). The acquisition was announced on January 10, 2023 and follows a track record of increasing collaboration between the two companies since 2019 as well as BioNTech’s initial equity investment as part of InstaDeep’s Series B financing round in January 2022.
The acquisition supports BioNTech’s strategy, aiming to build world-leading capabilities in AI-driven drug discovery and development of next-generation immunotherapies and vaccines to address diseases with high unmet medical need. InstaDeep will operate as a UK-based global subsidiary of BioNTech. In addition to BioNTech-focused projects, InstaDeep will continue to provide its services to clients around the world in diverse industries, including in the Technology, Transport & Logistics, Industrial, and Financial Services sectors. The transaction adds approximately 290 highly skilled professionals to BioNTech’s workforce, including teams in AI, ML, bioengineering, data science, and software development.
The total consideration to acquire the remaining InstaDeep shares, excluding the shares already owned by BioNTech, amounts to approximately €500 million in cash, BioNTech shares, and performance-based future milestone payments.
About InstaDeep
InstaDeep is a leader in decision-making AI systems with headquarters in London, and offices in Paris, Tunis, Lagos, Dubai, Cape Town, Berlin, Boston and San Francisco. InstaDeep was founded in 2014 in North Africa and has been named for three consecutive years to CB Insights’ influential AI 100 ranking, which showcases the 100 most innovative private artificial intelligence companies in the world. It was also named in 2022 as one of Europe’s 100 most promising B2B companies by the Financial Times-backed media site Sifted. With expertise in both machine intelligence research and concrete business deployments, InstaDeep gives its partners a competitive advantage in an AI-first world. Leveraging its extensive know-how in GPU-accelerated computing, deep learning and reinforcement learning, InstaDeep products, such as its DeepChainTM protein design platform, tackle the most complex challenges across a range of industries. InstaDeep has also developed collaborations with global leaders in the AI ecosystem, such as Nvidia and Google Cloud and has published joint research with DeepMind.
Latest news
IPCEI funding approval paves way for progress at bp’s Lingen green hydrogen project
bp’s 100MW industrial-scale green hydrogen project awarded funding, provided jointly by BMWK and Lower-Saxony Government, as part of the European IPCEI (Important Projects of Common European intere...
German and state governments grant funding for large hydrogen projects by RWE at Lingen, Germany
Electrolyser plant in Lingen and hydrogen storage facility in Epe to be funded with a total of 619 million euros Rostock electrolysis project with RWE participation to receive 199 million euros F...
Europe’s first hydrogen fuelled power plant supporting the UK’s decarbonisation at Essars refinery in Stanlow, UK
EET Hydrogen Power announces the development of Europe’s first 100% hydrogen fuelled power plant. Hydrogen fuelled power is an essential part of decarbonisation of industry and the power system in ...
Boehringer Ingelheim produces its own green energy in Ingelheim, Germany
German Vice Chancellor and Federal Minister of Economics Robert Habeck inaugurates new biomass power plant Ingelheim site can cover 95% of its energy needs from renewable sources New power plant ...